Suicide risk assessment: Is clinical experience enough?

Journal of the American Academy of Psychiatry and the Law

Volumn 34, Issue 3, 2006, Pages 276-278

  Simon, Robert I ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LITHIUM;

ANXIETY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; EXPERIENCE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MENTAL DISEASE; META ANALYSIS; MOOD DISORDER; PANIC; PSYCHIATRIST; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCHIZOPHRENIA; SUICIDE ATTEMPT; SYSTEMATIC REVIEW;

CLINICAL COMPETENCE; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; HUMANS; MALPRACTICE; RISK ASSESSMENT; SUICIDE; UNITED STATES;

EID: 33845983233     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Simon RI: Standard of care testimony: best practices or reasonable care? J Am Acad Psychiatry Law 33:8-11, 2005
2. Simon RI, Shuman DW: The standard of care in suicide risk assessment: an elusive concept. CNS Spectrum 11:6-9, 2006
3. Sheiber SC, Kramer TSM, Adamowski SE: Core Competence for Psychiatric Practice: What Clinicians Need to Know. Arlington, VA: American Psychiatric Publishing, Inc., 2003
4. Simon RI: Suicide risk: assessing the unpredictable, in American Psychiatric Publishing Textbook of Suicide Assessment and Management. Edited by Simon RI, Hales RE. Arlington, VA: American Psychiatric Publishing, Inc., 2006, pp 1-32
5. Simon RI: Assessing and Managing Suicide Risk: Guidelines for Clinically Based Risk Management. Arlington, VA: American Psychiatric Publishing, Inc., 2004
6. Fawcett J, Scheftner WA, Fogg L, et al: Time-related predictors of suicide in major affective disorder. Am J Psychiatry 147:1189-94, 1990
7. Harris EC, Barraclough B: Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 170:205-28, 1997
8. Baldessarini RJ, Tondo L, Hennen J: Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry 64(Suppl 5):44-52, 2003
9. Meltzer Y, Alphs L, Green AI, et al: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60:82-91, 2003
10. Linehan MM, Goodstein JL, Nielsen SL, et al: Reasons for staying alive when you are thinking of killing yourself: the reasons for living inventory. J Consult Clin Psychol 51:276-86, 1983
11. Simon RI: Imminent suicide: the illusion of short-term prediction. Suicide Life Threat Behav 36:296-301, 2006
12. Isometsa ET, Lonnqvist JK: Suicide attempts preceding completed suicide. Br J Psychiatry 173:521-35, 1998
13. Warman DM, Forman E, Henriques GR, et al: Suicidality and psychosis: beyond depression and hopelessness. Suicide Life Threat Behav 34:77-99, 2003
14. Coryell W, Leon A, Winokur G, et al: Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 153:483-9, 1996
15. American Psychiatric Association: Practice Guidelines for the Assessment and Treatment of Patients With Suicidal Behaviors. Am J Psychiatry 160(suppl):1-60, 2003
16. Gray GE: Evidence-Based Psychiatry. Arlington, VA: American Psychiatric Publishing, Inc., 2004
17. Simon RI: Suicide risk assessment: what is the standard of care? J Am Acad Psychiatry Law 30:340-4, 2002
18. Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)